LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 113 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,895 | -45.9% | 7,244 | +13.8% | 0.00% | – |
| Q2 2023 | $14,581 | +108.3% | 6,368 | +121.0% | 0.00% | – |
| Q1 2023 | $7,001 | +16.7% | 2,882 | -12.0% | 0.00% | – |
| Q4 2022 | $6,000 | -25.0% | 3,274 | -9.4% | 0.00% | – |
| Q3 2022 | $8,000 | +100.0% | 3,614 | +39.5% | 0.00% | – |
| Q2 2022 | $4,000 | 0.0% | 2,591 | +4.4% | 0.00% | – |
| Q1 2022 | $4,000 | -60.0% | 2,482 | -3.0% | 0.00% | – |
| Q4 2021 | $10,000 | +42.9% | 2,559 | +67.9% | 0.00% | – |
| Q3 2021 | $7,000 | +16.7% | 1,524 | +15.1% | 0.00% | – |
| Q2 2021 | $6,000 | -40.0% | 1,324 | -21.6% | 0.00% | – |
| Q1 2021 | $10,000 | +100.0% | 1,689 | -5.6% | 0.00% | – |
| Q4 2020 | $5,000 | +400.0% | 1,790 | +56.5% | 0.00% | – |
| Q3 2020 | $1,000 | -80.0% | 1,144 | -56.3% | 0.00% | – |
| Q2 2020 | $5,000 | +25.0% | 2,620 | +16.7% | 0.00% | – |
| Q1 2020 | $4,000 | – | 2,245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $25,366,000 | 100.00% |
| Artal Group S.A. | 71,178,364 | $417,817,000 | 7.38% |
| BVF INC/IL | 8,394,000 | $49,273,000 | 1.85% |
| Boothe Investment Group, Inc. | 435,939 | $2,559,000 | 1.49% |
| Campbell & CO Investment Adviser LLC | 103,100 | $605,000 | 0.37% |
| NEA Management Company, LLC | 2,382,286 | $13,984,000 | 0.31% |
| PINNACLE ASSOCIATES LTD | 2,167,172 | $12,721,000 | 0.24% |
| Eversept Partners, LP | 410,593 | $2,410,181 | 0.18% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $210,000 | 0.12% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 66,299 | $389,000 | 0.08% |